Image

A Multicenter Randomized Double Blind Placebo Controlled Parallel Group Pilot Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects with Relapsing-remitting Multiple Sclerosis

Investigating the Safety and Tolerability of an Investigational Medication in Relapsing-Remitting Multiple Sclerosis (RRMS)

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the safety and tolerability of an investigational medication in individuals with Relapsing-Remitting Multiple Sclerosis (RRMS). RRMS is a type of multiple sclerosis characterized by periods of new or increasing neurological symptoms followed by periods of partial or complete recovery. The study focuses on participants who have not responded well to high-dose intravenous or oral steroid treatments.

Participants will receive the investigational medication and will be monitored for their response to the treatment. The study will assess how well the medication is tolerated and whether it is safe for use in people with RRMS. Participants will be compensated for their time and involvement in the study.

  • Who can participate: Adults diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS) who have relapsed within 25 days before the study may qualify. Participants must have previously received specific steroid treatments and should not have used the investigational medication for MS treatment.
  • Study details: Participants will receive subcutaneous injections of an investigational medication. A placebo is not used in this study. Participants' responses to the treatment will be monitored to determine its safety and tolerability.
Print
Study details
    relapsing-remitting multiple sclerosis

TX8265

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.